Bristol-Myers Squibb: Top Defensive Pick In Recessions With A Value Proposition (NYSE:BMY)

0

PM Images

Bristol-Myers Squibb (NYSE:BMY) has been a lackluster major pharmaceutical pick for investors for years. For example, total returns of +19.6% over the last five years have lagged the S&P 500 index badly (+66.7%), while delivering just half the gains witnessed by

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Please enter CoinGecko Free Api Key to get this plugin works.